PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Sharewise Presentation 22/7/24, page-69

  1. 1,061 Posts.
    lightbulb Created with Sketch. 532
    Hi Mozza, i am usually able to follow your analysis quite easily, but i don't follow your response to @MixedBag or his comments before. You 2 are on a higher level. Can you expand on whether you think PAR are changing course somewhat in the upcoming trials and why, please?

    BTW it seems that either a deal or a CR is unavoidable. IMO. DYOR.
    I have pointed out to Simon White that another company has obtained funding at 3.5% (yep 3.5%) discount for their non-revenue earning company's R&D*, and suggested that PAR look to other than Bell Potter next time.
    Maybe some of you should raise your concerns about a CR through whom, with Simon..

    *I don't want to promote it here, but they were in a trading halt until today, and I hold them. My point is there are other ways to raise capital than PAR have been using.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.